OTCMKTS:THERF - Theratechnologies Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$6.4570 +0.17 (+2.66 %)
(As of 01/23/2019 02:25 AM ET)
Previous Close$6.29
Today's Range$6.30 - $6.63
52-Week Range$5.1480 - $11.25
Volume47,922 shs
Average Volume48,864 shs
Market Capitalization$496.40 million
P/E RatioN/A
Dividend YieldN/A
Beta0.64
Theratechnologies Inc., a specialty pharmaceutical company, addresses unmet medical needs to promote healthy living and improve quality of life among HIV patients. The company's lead product is EGRIFTA, which increases the incidence or progression of diabetic retinopathy in diabetic HIV-infected patients with lipodystrophy and excess abdominal fat in the United States and Canada. Theratechnologies Inc. was founded in 1993 and is headquartered in Montreal, Canada.

Receive THERF News and Ratings via Email

Sign-up to receive the latest news and ratings for THERF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:THERF
Previous SymbolNASDAQ:THER
CUSIPN/A
Phone514-336-7800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$32.93 million
Book Value$0.44 per share

Profitability

Net Income$-14,170,000.00

Miscellaneous

Employees28
Market Cap$496.40 million
OptionableNot Optionable

Theratechnologies (OTCMKTS:THERF) Frequently Asked Questions

What is Theratechnologies' stock symbol?

Theratechnologies trades on the OTCMKTS under the ticker symbol "THERF."

How were Theratechnologies' earnings last quarter?

Theratechnologies Inc (OTCMKTS:THERF) announced its quarterly earnings data on Thursday, April, 5th. The company reported ($0.03) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.01. The business had revenue of $8.12 million for the quarter. Theratechnologies had a negative net margin of 17.11% and a negative return on equity of 17.75%. View Theratechnologies' Earnings History.

When is Theratechnologies' next earnings date?

Theratechnologies is scheduled to release their next quarterly earnings announcement on Wednesday, February 6th 2019. View Earnings Estimates for Theratechnologies.

What is the consensus analysts' recommendation for Theratechnologies?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Theratechnologies in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Theratechnologies.

Has Theratechnologies been receiving favorable news coverage?

News headlines about THERF stock have been trending very positive this week, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Theratechnologies earned a media sentiment score of 3.4 on InfoTrie's scale. They also gave news stories about the company a news buzz of 1.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future.

Who are some of Theratechnologies' key competitors?

Who are Theratechnologies' key executives?

Theratechnologies' management team includes the folowing people:
  • Mr. Luc Tanguay, Pres, CEO & Non-Independent Director (Age 61)
  • Mr. Philippe Dubuc, Sr. VP & CFO (Age 52)
  • Mr. Jocelyn Lafond, VP of Legal Affairs & Corp. Sec. (Age 51)
  • Mr. Christian Marsolais, Sr. VP & Chief Medical Officer (Age 56)
  • Mr. Denis Boucher B.A., L.L.B., VP of Communications & Corp. Affairs (Age 53)

How do I buy shares of Theratechnologies?

Shares of THERF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Theratechnologies' stock price today?

One share of THERF stock can currently be purchased for approximately $6.4570.

How big of a company is Theratechnologies?

Theratechnologies has a market capitalization of $496.40 million and generates $32.93 million in revenue each year. Theratechnologies employs 28 workers across the globe.

What is Theratechnologies' official website?

The official website for Theratechnologies is http://www.theratech.com.

How can I contact Theratechnologies?

Theratechnologies' mailing address is 2015 Peel Street 5th Floor, MONTREAL A8, H3A 1T8. The company can be reached via phone at 514-336-7800 or via email at [email protected]


MarketBeat Community Rating for Theratechnologies (OTCMKTS THERF)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  61 (Vote Outperform)
Underperform Votes:  61 (Vote Underperform)
Total Votes:  122
MarketBeat's community ratings are surveys of what our community members think about Theratechnologies and other stocks. Vote "Outperform" if you believe THERF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe THERF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2019 by MarketBeat.com Staff

Featured Article: Dividend Aristocrat Index

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel